Biochemical Journal

Papers
(The H4-Index of Biochemical Journal is 30. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-11-01 to 2025-11-01.)
ArticleCitations
Michael D. Waterfield961
A highly conserved ligand-binding site for AccA transporters of antibiotic and quorum-sensing regulator in Agrobacterium leads to a different specificity224
Cas11 augments Cascade functions in type I-E CRISPR system but is redundant for gene silencing and plasmid interference217
Development of an OTUD1 ubiquitin variant inhibitor114
Divergent roles of DRY and NPxxY motifs in selective activation of downstream signalling by the apelin receptor75
Identification of inhibitors of human ChaC1, a cytoplasmic glutathione degrading enzyme through high throughput screens in yeast73
Respiratory epithelial cell types, states and fates in the era of single-cell RNA-sequencing61
Mutational insights into human kynurenine aminotransferase 1: modulation of transamination and β-elimination activities across diverse substrates61
A curated list of targeted optimized promiscuous ketoreductases (TOP-K)59
In search for structural targets for engineering d-amino acid transaminase: modulation of pH optimum and substrate specificity56
Programmed cell death: the pathways to severe COVID-19?55
Up-regulation of the PI3K/AKT and RHO/RAC/PAK signalling pathways in CHK1 inhibitor resistant Eµ-Myc lymphoma cells54
Aurora A binds to the transactivation domain of c-Myc and recognizes the phosphorylated N-terminal degron motif54
Basic features of cellular inositol metabolism as revealed by a newly developed LC-MS method53
Novel phosphatidylinositol flippases contribute to phosphoinositide homeostasis in the plasma membrane51
A guide to ERK dynamics, part 2: downstream decoding51
Combinatorial approaches for mitigating resistance to KRAS-targeted therapies48
Gain of function of a metalloproteinase associated with multiple myeloma, bicuspid aortic valve, and Von Hippel–Lindau syndrome46
Expression of neuronal NO synthase α- and β-isoforms in skeletal muscle of mice46
The C-terminal structure of the N6-methyladenosine deaminase YerA and its role in deamination45
Calcium signalling components underlying NPK homeostasis: potential avenues for exploration43
Adaptor protein 3BP2 regulates dectin-1-mediated cellular signalling to induce cytokine expression and NF-κB activation41
PKN2 deficiency leads both to prenatal ‘congenital’ cardiomyopathy and defective angiotensin II stress responses40
BH3 mimetics and TKI combined therapy for Chronic Myeloid Leukemia39
Improved furfural tolerance in Escherichia coli mediated by heterologous NADH-dependent benzyl alcohol dehydrogenases36
CORM-3 induces DNA damage through Ru(II) binding to DNA35
The atypical thioredoxin ‘Alr2205’, a newly identified partner of the typical 2-Cys-Peroxiredoxin, safeguards the cyanobacterium Anabaena from oxidative stress34
TOR complex 2 is a master regulator of plasma membrane homeostasis33
Serine acetyltransferase from Neisseria gonorrhoeae; structural and biochemical basis of inhibition33
A central role for amyloid fibrin microclots in long COVID/PASC: origins and therapeutic implications31
0.42038989067078